The International Air Transport Association (IATA)'s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) has recertified Dachser for its facilities in Hyderabad and Mumbai.

The transport of life science and healthcare products must meet strict requirements. Medicines, vaccines and other pharmaceuticals are often temperature-sensitive, urgent shipments that must be handled in accordance with highly complex regulations. As an industry standard, CEIV Pharma certification covers the specific requirements of pharmaceutical shippers for safe, correct and efficient air freight services.

The same standards apply for recertification as for initial certification. CEIV Pharma certification requires internal and external training, an assessment of procedures for handling temperature-controlled life science and healthcare shipments, and a comprehensive evaluation of these complex processes by an independent auditor.

“With the recertification, we confirm our capabilities in life science and healthcare in India,” said Timo Stroh, global head of airfreight and life science and healthcare logistics.

“We strive to meet the highest international standards when transporting sensitive products worldwide,” says Timo Stroh. “We are proud of this recertification and reaffirm our strong presence in the Indian market, despite the global impact of the Covid-19 pandemic. For the Business Field Solution Life Science and Healthcare Logistics at DACHSER, the Indian subcontinent is an essential pillar. "

CEIV Pharma provides the pharmaceutical industry with a globally uniform and recognized certification for the handling of pharmaceutical products that meets and exceeds international standards and guidelines. These include Good Distribution Practices (GDP) and the World Health Organization, United States Pharmacopeia standards, and IATA temperature control regulations.